Pule Ning (普乐宁)普乐宁
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 烟台鲁银药业有限公司Chinese legal name: 烟台鲁银药业有限公司
主要成分Active Ingredients
- 咖啡因组成的复方制剂Recorded Chinese composition: 咖啡因组成的复方制剂
药物知识说明
咖啡因组成的复方制剂是一种在国家药监局注册认定的药品。标注生产企业为烟台鲁银药业有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：烟台鲁银药业有限公司Chinese legal name: 烟台鲁银药业有限公司、烟台鲁银药业有限公司Chinese legal name: 烟台鲁银药业有限公司、烟台鲁银药业有限公司Chinese legal name: 烟台鲁银药业有限公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 普乐宁) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 烟台鲁银药业有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 烟台鲁银药业有限公司Chinese legal name: 烟台鲁银药业有限公司, 烟台鲁银药业有限公司Chinese legal name: 烟台鲁银药业有限公司, 烟台鲁银药业有限公司Chinese legal name: 烟台鲁银药业有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 普乐宁Recorded Chinese name: 普乐宁
- 剂型Dosage form: 颗粒剂Granules
- 规格Specification: 每克含对乙酰氨基酚0.5g、咖啡因65mg。每袋1克，10袋/盒。Recorded Chinese composition: 每克含对乙酰氨基酚0.5g、咖啡因65mg。每袋1克，10袋/盒。
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 烟台鲁银药业有限公司Chinese legal name: 烟台鲁银药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20020238
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20020238
Manufacturer
Chinese legal name: 烟台鲁银药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20020238
生产企业
烟台鲁银药业有限公司(国产)
适应症
1. 本品用于减轻或解除中等程度的各种疼痛(头疼、牙痛、关节痛、痛经等)以及因感冒等引起的发热症状。2. 酚咖颗粒是一种有显著镇痛作用，且起效迅速的镇痛药。对中重度伴有发热的病人同时有退热作用，且少见不良反应。酚咖颗粒每袋含对乙酰氨基酚500mg，咖啡因65mg。3. 对乙酰氨基酚是全球医生和消费者的首选镇痛解热药品，拥有较好的安全性，无嗜睡，不刺激胃肠，在推荐治疗剂量范围内无肝、肾毒性。对乙酰氨基酚通过抑制下丘脑前列腺素的合成，从而达到解热镇痛的作用。4. 咖啡因可以改变肝脏、胃部和回肠的微循环，增加胃部和回肠的血流，同时减少肝脏的血液循环，从而增加药物的吸收而减少肝内代谢;明显增加对乙酰氨基酚的生物利用度和吸收常数;咖啡因还可以减少谷胱甘肽的耗竭而防止对乙酰氨基酚的肝损作用。咖啡因是对乙酰氨基酚的良好佐剂，二者协同发挥作用，疗效显著。
用法用量
口服，成人每4至6小时服1-2袋，疼时服用。或遵医嘱，每日剂量不超过8袋。
不良反应
尚不明确。
禁忌
尚不明确。
注意事项
1. 如服药3天后发热不退或疼痛不减，应请医生诊治。2. 孕妇及哺乳期妇女服用本品前，应咨询医生。
规格
每克含对乙酰氨基酚0.5g、咖啡因65mg。每袋1克，10袋/盒。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.